Home Search

ovarian cancer - search results

If you're not happy with the results, please do another search
Illustration of female reproductive system including uterus and ovaries to represent ovarian cancer

Population-Wide Hereditary Breast, Ovarian Cancer Screening in Younger Women is Cost-Effective

The research suggests that wide screening of younger women for HBOC should be considered both to prevent more cancers and to help more women at low risk of breast cancer to avoid unnecessary additional screening.  
3d rendered ovarian cancer illustration.

Remote Screening Test for Ovarian Cancer Receives Study Validation

Between 2016 and 2020, a clinical trial engaged nearly 4,000 women from all 50 US states with the intention to validate different combinations of remote genetic counseling—the first large, randomized study of its kind to attempt to do so for cancer risk.
3d rendered ovarian cancer illustration.

Ovarian Cancer Cells’ Dependence on Fat Suggests New Therapeutic Target

The enzyme Carnitine Palmitoyltransferase 1A (CPT1A) may control how much fat ovarian cancer cells can burn, suggesting a treatment that limits these cells’ access to CPT1A may starve them of the resources they need to spread.
Ovary cancer

Single-Cell Sequencing Provides Insights into Ovarian Cancer Subtypes

The scientists were able to identify new subtypes of normal fallopian tube cells. The molecular fingerprints of the subtypes that were identified had many genetic mirrors in individual ovarian cancers, which suggests that there may be many specific subtypes of ovarian cancer.
Image showing breast cancer

Myriad Wins Japanese Approval for BRACAnalysis to Assess Breast, Ovarian Cancer Risk

Diagnostic system tests for BRCA mutations in order to assess risk of Hereditary Breast and Ovarian Cancer (HBOC) syndrome in women with breast cancer.
Ovary cancer

FDA Approves Myriad’s myChoice CDx for Zejula’s Late-Line Ovarian Cancer Indication

The FDA has approved Myriad Genetics’ myChoice CDx as a companion diagnostic for Zejula (niraparib) to identify women with advanced ovarian cancer in the...

FoundationOne CDx Approved as Companion Diagnostic to Lynparza in Ovarian Cancer

The FDA has approved an expanded indication for Foundation Medicine’s FoundationOne®CDx, authorizing the test as a companion diagnostic for the AstraZeneca/Merck & Co. co-developed...
Illustration of female reproductive system including uterus and ovaries to represent ovarian cancer

Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery

Scientists at Uppsala University and the Sahlgrenska Academy, University of Gothenburg say they have developed a blood test that may provide a more precise...
3d rendered ovarian cancer illustration.

Genetic Testing for Ovarian Cancer Patients is Underused

Patients with ovarian cancer are not getting all the testing they need, according to study a recently published in Journal of Clinical Oncology. Breast and...
A blood sample being held with a row of human samples for analytical testing including blood, urine, chemistry, proteins, anticoagulants and HIV in lab

Liquid Biopsies Provide Precision Approach to Ovarian Cancer Treatment

Scientists based at the University of Helsinki reported they were able to use the circulating tumor DNA shed by ovarian tumors to identify clinically actionable mutations and provide targeted treatments to patients.


Inside Precision Medicine